The toll of long-term exposure is about equal to an extra year of brain aging.
International Stroke Conference News
A drug that originally cost $8,700 a year now costs $62,400 a year.
The topical gel may be suitable for patients who experience gastrointestinal side effects from oral NSAIDs.
Those already addicted may be seeking illicit narcotics as a substitute, contributing to the surge in heroin use.
The results support the “cognitive reserve” theory that greater mental activity promotes brain connectivity.
Genervon has requested accelerated approval from the FDA for its experimental ALS drug, GM604.
Investigational multiple sclerosis drug MD1003 delivers 300 mg/day of biotin, a huge increase the usually recommended dose of 30-100 mcg/day.
Compared with APOE ε4, APOE ε2 seems to have an indirect effect on cognition by influencing AD pathology.
The app’s data easily exports so that physicians have access to accurate, long- and short-term outcomes for patients.
Uncertainty about when to order imaging studies, existing guidelines on migraine preventive treatments common.
Common Parkinson’s hallucinations replicated using Oculus Rift headset.
30 mg of suvorexant improved PRO and PSG measures of sleep maintenance and sleep onset at the earliest time points.
Those who drank larger amounts of hard alcohol had the strongest association with lower EDSS.
Sleep problems are common in patients with stroke and may contribute to declines in cognitive performance.
Personalized obstetrical care may be warranted during intrapartum period.
Outgoing AAN president Timothy Pedley, MD, spoke of greater utilization of advanced practice professionals to better serve patients.
Speech impairment previously thought irreversible show incremental improvement with the experimental treatment.
Researchers found that those who had an affected sibling and received an MMR dose by age 2 were 25% less likely to have autism.
Threshold-tracking transcranial magnetic stimulation could be a useful diagnostic technique in the clinical setting.
A topographical model of multiple sclerosis uses animation to illustrate the continuum of the disease.
The positive correlation could mean that migraineurs are unable to direct attention away from painful stimuli.
In-hospital mortality was significantly lower despite longer overall stays.
The well-tolerated treatment helped sustain migraine relief more than 48-hours post-dose.
Total annual healthcare costs per patient increase incrementally with each dose.
Waiting times for assessment were reduced by approximately 70% compared with the standard model.
FDA is reviewing a supplemental new drug application to expand the indication for eslicarbazepine acetate (ESL) as a monotherapy.
Nearly 40% of clinically-stable patients who stopped taking medication recorded a relapse or disability progression.
People with MS that currently use marijuana are likely to report higher levels of disability and more recent relapse.
The EMG device is discreet and easy to wear, weighing only 6.5 ounces.
The guidelines encourage doctors to have a meaningful conversation with their patients to evaluate risks and benefits of treatment.